Operating Lease, Right-of-Use Asset in USD of Emmaus Life Sciences, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Emmaus Life Sciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • Emmaus Life Sciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $799K, a 53.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Emmaus Life Sciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $799K -$920K -53.5% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $830K -$1.07M -56.4% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $1.33M -$751K -36.1% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $1.53M -$807K -34.5% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 $1.72M -$791K -31.5% 30 Sep 2024 10-Q 19 Nov 2024
Q2 2024 $1.9M -$682K -26.4% 30 Jun 2024 10-Q 10 Sep 2024
Q1 2024 $2.08M -$564K -21.3% 31 Mar 2024 10-Q 10 Sep 2024
Q4 2023 $2.34M -$462K -16.5% 31 Dec 2023 10-K 14 Apr 2025
Q3 2023 $2.51M -$434K -14.7% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $2.59M -$500K -16.2% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $2.65M -$672K -20.3% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $2.8M -$686K -19.7% 31 Dec 2022 10-K 03 Jul 2024
Q3 2022 $2.94M -$698K -19.2% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $3.09M -$711K -18.7% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $3.32M -$629K -15.9% 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $3.49M -$587K -14.4% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $3.64M -$503K -12.1% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $3.8M -$487K -11.4% 30 Jun 2021 10-Q 01 Sep 2021
Q1 2021 $3.95M -$397K -9.14% 31 Mar 2021 10-Q 01 Sep 2021
Q4 2020 $4.07M -$402K -8.99% 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $4.15M +$27K +0.66% 30 Sep 2020 10-Q 26 Aug 2021
Q2 2020 $4.28M -$2K -0.05% 30 Jun 2020 10-Q 26 Aug 2021
Q1 2020 $4.34M +$1.51M +53.1% 31 Mar 2020 10-Q 26 Aug 2021
Q4 2019 $4.47M 31 Dec 2019 10-Q 26 Aug 2021
Q3 2019 $4.12M 30 Sep 2019 10-K 25 Jan 2021
Q2 2019 $4.29M 30 Jun 2019 10-Q 26 Aug 2021
Q1 2019 $2.84M 31 Mar 2019 10-Q 26 Aug 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.